← FDA Drug Approvals (Drugs@FDA)
TACROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HANGZHOU ZHONGMEI · Approved 2023-04-17
Drug application
- FDA Application #
ANDA210929- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TACROLIMUS
- Generic name
- TACROLIMUS
- Active ingredients
- TACROLIMUS
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- HANGZHOU ZHONGMEI
- Manufacturer
- Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd
- First approval
- 2023-04-17
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown